ABBY MELTON: Open Payments
NPI 1780908186 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 26 payments from 10 companies in 2025. Trend: 2023 $295 · 2024 $455 · 2025 $658
Food & beverage: $658
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $260 |
| Regeneron Healthcare Solutions, Inc. | 5 | $152 |
| Amgen Inc. | 4 | $75 |
| Galderma Laboratories, L.P. | 2 | $33 |
| UCB, Inc. | 1 | $32 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $22 |
| PFIZER INC. | 1 | $16 |
| ABBVIE INC. | 1 | $14 |
Products named: DUPIXENT, COSENTYX, OTEZLA, NEMLUVIO, Bimzelx, ILUMYA, SPEVIGO, CIBINQO.
Industry payments across AL — which companies pay providers there.
